MIRIXA CORPORATION – Trademark Portfolio
Entity Type: 03
MIRIXA CORPORATION holds 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 44 (Medical Services) — 5 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 3 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include MIRIXA and THE POWER OF PHARMACY. The owner is based in RESTON, VA.
11600 SUNRISE VALLEY DRIVE
SUITE 100
RESTON, VA 20191
Showing of trademarks Trademarks
Trademark Classifications
MIRIXA CORPORATION's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Scientific and technological services; industrial analysis and research services
Education; providing of training; entertainment; sporting and cultural activities
Frequently Asked Questions
How many trademarks does MIRIXA CORPORATION have?
MIRIXA CORPORATION has 5 U.S. trademarks filed with the USPTO. Of these, 3 registered, 2 abandoned.
What trademark classes does MIRIXA CORPORATION file in?
MIRIXA CORPORATION files trademarks across 3 Nice Classification classes. The most active classes are Class 44 (Medical Services), Class 42 (Computer & Scientific), Class 41 (Education & Entertainment). Class 44 covers medical services; veterinary services; hygienic and beauty care for human beings or animals.
What are MIRIXA CORPORATION's most well-known trademarks?
MIRIXA CORPORATION's registered trademark portfolio includes well-known marks such as MIRIXA and THE POWER OF PHARMACY. These are among 3 currently registered trademarks in the portfolio.
What is MIRIXA CORPORATION's trademark registration success rate?
MIRIXA CORPORATION has a 60% trademark registration rate, with 3 out of 5 resolved applications resulting in successful registration. Currently, 0 applications are pending review.